GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SynCore Biotechnology Co Ltd (ROCO:4192) » Definitions » Cyclically Adjusted Book per Share

SynCore Biotechnology Co (ROCO:4192) Cyclically Adjusted Book per Share : NT$37.59 (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is SynCore Biotechnology Co Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

SynCore Biotechnology Co's adjusted book value per share for the three months ended in Mar. 2024 was NT$9.931. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is NT$37.59 for the trailing ten years ended in Mar. 2024.

During the past 12 months, SynCore Biotechnology Co's average Cyclically Adjusted Book Growth Rate was -5.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2024-05-24), SynCore Biotechnology Co's current stock price is NT$44.35. SynCore Biotechnology Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was NT$37.59. SynCore Biotechnology Co's Cyclically Adjusted PB Ratio of today is 1.18.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of SynCore Biotechnology Co was 2.44. The lowest was 0.92. And the median was 1.22.


SynCore Biotechnology Co Cyclically Adjusted Book per Share Historical Data

The historical data trend for SynCore Biotechnology Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SynCore Biotechnology Co Cyclically Adjusted Book per Share Chart

SynCore Biotechnology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 39.84 37.62

SynCore Biotechnology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 39.80 39.34 38.81 37.62 37.59

Competitive Comparison of SynCore Biotechnology Co's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, SynCore Biotechnology Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SynCore Biotechnology Co's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SynCore Biotechnology Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where SynCore Biotechnology Co's Cyclically Adjusted PB Ratio falls into.



SynCore Biotechnology Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, SynCore Biotechnology Co's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=9.931/131.7762*131.7762
=9.931

Current CPI (Mar. 2024) = 131.7762.

SynCore Biotechnology Co Quarterly Data

Book Value per Share CPI Adj_Book
201406 34.372 100.560 45.042
201409 26.779 100.428 35.138
201412 56.279 99.070 74.859
201503 66.212 99.621 87.584
201506 57.737 100.684 75.567
201509 49.940 100.392 65.552
201512 52.894 99.792 69.847
201603 47.456 100.470 62.243
201606 42.246 101.688 54.746
201609 52.807 101.861 68.316
201612 50.964 101.863 65.930
201703 47.247 102.862 60.528
201706 44.079 103.349 56.203
201709 41.707 104.136 52.777
201712 38.004 104.011 48.149
201803 35.989 105.290 45.042
201806 31.090 106.317 38.535
201809 36.989 106.507 45.765
201812 31.235 105.998 38.831
201903 28.739 107.251 35.311
201906 23.042 108.070 28.097
201909 28.050 108.329 34.121
201912 23.161 108.420 28.150
202003 20.017 108.902 24.222
202006 26.760 108.767 32.421
202009 23.038 109.815 27.645
202012 19.381 109.897 23.240
202103 26.851 111.754 31.662
202106 24.035 114.631 27.630
202109 16.982 115.734 19.336
202112 14.182 117.630 15.888
202203 12.928 121.301 14.044
202206 11.598 125.017 12.225
202209 10.568 125.227 11.121
202212 7.973 125.222 8.390
202303 7.155 127.348 7.404
202306 6.343 128.729 6.493
202309 5.371 129.860 5.450
202312 10.156 129.419 10.341
202403 9.931 131.776 9.931

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


SynCore Biotechnology Co  (ROCO:4192) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

SynCore Biotechnology Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=44.35/37.59
=1.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of SynCore Biotechnology Co was 2.44. The lowest was 0.92. And the median was 1.22.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


SynCore Biotechnology Co Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of SynCore Biotechnology Co's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


SynCore Biotechnology Co (ROCO:4192) Business Description

Traded in Other Exchanges
N/A
Address
No.84 Zhongshan Road, Zhongshan Village, Dongshan Township, Yilan, TWN, 269
SynCore Biotechnology Co Ltd is a biopharmaceutical company. Its pipeline products concentrate on the ophthalmology, oncology, and dermatology fields. The pipeline products of the company include SB01 and 02, SB03, SB04, and SB05. It is engaged in drug development and sale, food advisory, medicine inspection, biotechnology service and intellectual property. It operates in a single industry, the new drug development.

SynCore Biotechnology Co (ROCO:4192) Headlines

No Headlines